Our Frontline Insights series of expert discussions dives into the critical aspects of type 1 diabetes, from early detection and intervention to the latest treatment advancements. Our esteemed panel of experts discuss the impact of early screening, the role of teplizumab therapy, and the importance of timely intervention in delaying disease progression and improving patient outcomes.